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Summary 
During  their  differentiation  in  the  mouse  thymus,  CD4+8 -  cells  undergo  several  of the 
sequential changes observed upon normal activation of mature, peripheral CD4 § lymphocytes. 
Expression of CD69,  an early activation marker, is first observed on a minority of cells at the 
T  cell receptor (TCR.)  l~  double-positive stage,  is maximal (50-90%) on heat-stable antigen 
(HSA)  hi TCR  hi double-positive, HSA  hi TCP~  med CD4+81~  and HSA  hi TCI~  hi CD4+8 -  cells, and 
is downmodulated at the mature HSA  l~ CD4+8 -  stage.  In contrast, CD44,  a late activation 
marker,  is  selectively expressed at  the HSA  l~ stage.  The  set  of lymphokines that  CD4+8 - 
thymocytes can produce upon stimulation also characteristically expands from mainly interleukin 
2 (IL-2) at the HSA  hi stage,  to Ib2 and very large amounts of IL-4, IL-5, IL-10, and interferon 
3/ (IFN-3/)  at the HSA  l~ stage.  1 in 30 HSA  1~ CD4+8 -  adult  thymocytes secrete Ib4  upon 
stimulation through their TCK. This frequency is 25% of the frequency of IL-2 producers, about 
100-fold  above  that  of peripheral  (mainly  resting)  CD4 +  T  cells.  With  time  after  their 
generation in organ culture, CD4 § 8-  thymocytes lose their capacity to secrete IL-4, IL-5, and 
IFN-% but not IL-2. Similarly, the frequency of Ib4, but not of Ib2, producers progressively 
decreases after emigration to the periphery as judged by direct comparison between thymic and 
splenic CD4 + cells in newborns, or by following the fate of intrathymically labeled CD4+8 - 
cells in adults after their migration to the spleen. This sequence suggests that thymic selection 
results from an activation process rather than a simple rescue from death at the double-positive 
stage, and shows that the functional changes induced after intrathymic activation, although transient, 
are still  evident after export to the periphery. 
W 
hen stimulated, mature peripheral CD4 § T lympho- 
cytes secrete two different sets of lymphokines de- 
pending on their previous state of activation. Thus, resting 
peripheral CD4 + T cells mainly secrete the lymphokine I1.-2 
for a few days before reverting to the resting state,  whereas 
preactivated cells produce a large panel of other lymphokines, 
including IL-4, Ib5,  and IFN-3/(1-6).  This secondary set 
of lymphokines is transiently observed at high levels upon 
reactivation, for 3-7 d after the initial stimulation, i.e., during 
the blast stage, and seems to be rapidly downmodulated after 
resting, both in vitro and in vivo (3,  7-8). 
We  have  previously reported  that  new  CD4+8 -  cells 
generated in the thymus behave like recently activated cells 
(9). In their early, immature phase, characterized by high sur- 
face expression of the heat-stable antigen (HSA), 1 CD4+8 - 
thymocytes secrete mainly IL-2 after stimulation by the com- 
bination of ionomycin and PMA (TCR crosslinking failed 
t Abbreviation used in this  paper." HSA,  heat-stable antigen. 
to  induce  lymphokine  secretion  at  that  stage).  Mature 
(HSA  l~  CD4+8 -  cells,  however,  secrete a wide range of 
lymphokines, including Ib2 and large amounts of the sec- 
ondary set of lymphokines, particularly II.-4, and Ib5, Ibl0, 
and IFN-3/upon stimulation by either TCR crosslinking or 
the combination of ionomycin and PMA. The magnitude 
of IL-4 secretion is  on average 240-fold  greater than that 
elicitable from other lymphoid organs, including peripheral 
and mesenteric lymph nodes, spleen, blood, and thoracic duct. 
Since the same phenotype was found in adult and in new- 
born thymuses, as well as in fetal thymic organ culture, we 
argued  that  the thymic environment itself generates  this 
activation-like process. 
Here, we have traced the origins and the fate of the IL-4 
producer CD4 +  8-  cells generated in the thymus, by mea- 
suring their frequency in different in vivo and in vitro systems. 
We show that they follow the mainstream cell production 
and export by the thymus. We provide further evidence that 
the IL-4 producer state results from an intrathymic activation 
process by showing that CD69 and CD44, early and late ac- 
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the maturation of these II.,4 producer CD4 +  8-  thymocytes. 
Finally, we speculate on the relationship between these acti- 
vation events  and  the  thymic  selection  process. 
Materials and Methods 
Mice.  5-wk-old,  specific  pathogen-free  BALB/c,  C57BL/6, 
BALB/c  x  C57BL/6, and AKR mice were obtained from C. Reeder 
(National  Cancer Institute,  Frederick,  MD)  and housed in our 
specific pathogen-free facility for I wk before use. Day 13 fetuses 
were extracted from timed-pregnant C57BL/6 mice 13 d after vag- 
inal plugs were observed. 
Fetal Thymic Organ Cultures.  Thymic lobes from day 13 fetuses 
were cultured  on microporous membranes on top of 1.8 ml of 
Iscove's modified DMEM (IMDM; Biofluids,  Rockville, MD) en- 
riched with 10% heat inactivated FCS, glutamine, antibiotics, and 
5  x  10 -s M  2-ME in six-well  plates  (Transwells;  Costar, Cam- 
bridge, MA), at a density of 10 lobes per well, at 37~  in a 5% 
COz atmosphere.  Half the  medium was changed  at day 6  and 
twice a week thereafter. 
FACS  |  Analysis and Sorting of Thymic and Peripheral T  Cell 
Subsets.  Spleen  or thymic cell suspensions were panned at 4~ 
for 30 min on plates coated with the anti-CD8 mAb 2.43 at 10 
/xg/ml, and CDS-depleted preparations were further purified,  after 
CD4 staining with allophycocyanin (APC)-conjugated GK1.5 mAb 
and CD8 staining with 53.6.7-FITC by sorting using a dual laser 
instrument (FACStar  Plus|  Becton Dickinson & Co., Mountain 
View,  CA).  HSA  l~  thymocytes  were  identified  by  additional 
staining with biotinylated M1/69 mAb (10) followed by streptavidin- 
PE, and they were sorted within a gate set to include 95% of pe- 
ripheral CD4 + T cells. They represented 20-30% of all CD4+8 - 
thymocytes in  adult  mice.  We have  previously shown  that  the 
majority of thymocytes that are able to secrete lymphokines upon 
TCR crosslinking are contained in this gate (9).  The activation 
process  on  developing  thymocytes  was  followed  by  four-color 
staining and analysis on the FACStar Plus  |  instrument using exci- 
tation wavelengths of 488 and 600 nm for the argon and dye lasers, 
respectively.  Cells were stained with IM.78-FITC anti-CD44 (11) 
or H1.2F3-FITC anti-CD69 (12) (Pharmingen, San Diego, CA), 
and GK1.5-APC anti-CD4, 53.6.7-biotin anti-CD8 (Becton Dick- 
inson & Co.), revealed with streptavidin-Texas red (Molecular Probes, 
Eugene, OR), H57-PE anfi-TCR-ot/fl (13) (Pliarmingen)  or M1/69- 
PE anti-HSA, in the presence of anti-Fc receptor 2.4G2 antibodies 
to block nonspecific binding. The whole staining procedure was 
performed in ice-cold PBS containing 1% BSA and 0.1% sodium 
azide. As specificity controls, staining for CD69-FITC and CD44- 
FITC were completely abolished by a 100-fold excess of unlabeled 
purified anti-CD69  or anti-CD44  antibody, respectively. 
Recent Thymic Migrant Assay.  Adult C57BL/6 mice were anes- 
thesized by intraperitoneal injection of 0.2 ml of a mixture con- 
taining 0.2 mg of ketamine (parke-Davis, Morris Plains,  NJ) and 
2 mg of Xylazine (Haver, Shawnee, KS), and each thymic lobe was 
injected with 10 #1 of a solution of FITC (Research Organics Inc., 
Cleveland, OH) at 0.5 mg/ml in PBS as described by ScoUay et 
al.  (14).  Groups of 10-15  mice were killed  10 h  later,  and their 
spleen  cells were pooled and enriched in CD4 + cells by incuba- 
tion with anti-CD8 mAb 3.155 followed by panning on anti-mouse 
Ig-coated plates to remove CD8 § cells and B cells,  then passed 
on a lympholyte solution (Lympholyte-M; Cedarlane Laboratories, 
Hornby, Ontario, Canada) to remove red cells and dead cells, be- 
fore staining with GK1.5-APC anti-CD4 and FACS  |  sorting for 
CD4 § lymphocytes positive or negative for FITC. To follow the 
fate  of the recent  thymic migrants with  time,  some mice were 
thymectomized 48 h after intrathymic injection of FITC, and the 
FITC-positive cells present in the spleen were FACS  |  sorted 3 or 
6 d  after thymectomy. 
Limiting D~'htion Assays.  Specific indicator cell lines were used 
to detect single cells producing lymphokines as modified from Rocha 
and Bandeira (15) and Seder et al. (16). FACS  |  purified CD4 + T 
cells were plated at various numbers per well, at 30 replicates  per 
concentration  point,  in  round-bottomed  microwells containing 
1,000-rad irradiated,  dendritic cell-enriched accessory cells (200 cells 
per well), and Con A at 3/~g/ml (similar results were obtained 
with plate-bound anti-CD3 antibody), in a final volume of 30 #1 
of medium composed of a 1:1 mixture of Click's medium and RPMI 
(Biofluids, RockviUe, MD) enriched with 10% heat-inactivated FCS, 
glutamine,  antibiotics,  and  5  x  10 -5  M  2-ME.  The dendritic 
cell-enriched preparation was made from spleen cells adhered for 
2 h at 2  x  10  s cells in 10 ml in plates (Falcon 3003; Becton Dick- 
inson, Lincoln Park, NJ) with a cocktail of anti-T cell mAbs (JIJ.10 
anti-Thy-1,  172.4 anti-CD4, and 3.155 anti-CD8) and guinea pig 
complement at 1:10 added during the last 45 min of incubation. 
Nonadherent cells were removed by strong and repeated washings 
and the preparations reincubated for an additional 6 h, before col- 
lecting the detached cells and centrifuging them over a 50% per- 
coil solution (Pharmacia-LKB,  Uppsala, Sweden). Low density cells 
prepared in this way contained 80-95% dendritic cells specifically 
stained with biotinylated 33D1 antibody (17) and streptavidin-PE. 
Assay wells  destined to measure the frequency of Ib4 producers 
were supplemented with a source of exogenous human rlL-2  at 
10 U/ml (30 pM) (Hoffmann-La Roche, Basel, Switzerland). This 
is because,  in our culture conditions,  II.,4 secretion requires the 
presence of I1.-2 (2-3,  16). After 48 h of culture,  the plates were 
irradiated (1,000 tad) and the indicator cells were added in situ in 
a volume of 10 #1. IL-2-producing wells were detected by adding 
100 CTLL cells  (American Type Culture Collection,  Rockville, 
MD) with the anti-IL-4 mAb 11Bll  (18) at 30/~g/ml,  and 11.,4- 
producing wells by adding 500 IL-4-specific CT.4S cells (19) with 
a cocktail of anti-IL-2 ($4B6 [20], 20 #g/ml), and anti-IL-2R anti- 
bodies (PC 61 [21] and 7D4 [22] at 10/~g/ml and 1:100 final dilu- 
tion of an ammonium sulfate  semi-purified supernatant,  respec- 
tively). In these conditions, addition of antibodies specific for the 
lymphokine assayed always resulted in a 100% inhibition of detec- 
tion. Positive wells were scored 48 h later, usually by visual scoring 
of the wells containing live indicator cells. This method was shown 
to give excellent  correlation with scoring based on thymidine in- 
corporation by CT.4S cells at 48 h and by CTLL cells at 96 h. Con- 
trol wells where T cell responders were omitted always scored nega- 
tive. These assays can detect a frequency of one in one II_,4 producers 
in two different Th2-type CD4 + T  cell clones,  and 1 in 1.8 II.-2 
producers in one Thl-type CD4 § T  cell clone, with a single hit 
Poisson distribution (16, and data not shown). Frequencies and their 
95%  confidence interval limits were calculated according to the 
X  2 minimization method of Taswell (23), on a computer program 
designed by Dr. Steve Stringfellow (NOAA Pacific Fleet, Seattle, 
WA). 
Bulk In Vitro Stimulation of Lymphokine Secretion.  CD4 § cells 
at  10S/well  (except as  otherwise  stated)  were plated on round- 
bottomed microwells coated with 10/~g/ml of anti-TCR-a/fl mAb 
H57 (13), in the presence of 2-3  x  104 dendritic cell-enriched ac- 
cessory cells, and supernatants were collected at 48 h and kept frozen 
at  -20~  until assayed. The dose of stimulating antibodies and 
the time for collection of the supernatants had previously been de- 
732  Activation Events during  Thymic Selection termined to be optimal for the detection of maximal levels of all 
the lymphokines assayed. 
Lymphokine Assays.  I1.-2  was measured by the CTLL bioassay 
run in the presence of the anti-IL-4 mAb 11Bll at 30/~g/ml, and 
Ib4 by the IL-4 specific CT.4S bioassay run in the presence of the 
cocktail of anti-IL-2 and anti-IL-2R antibodies described above. The 
spedficity of the two bioassays in these conditions was demonstrated 
by the complete blocking of the indicator cell proliferation by the 
homologous neutralizing antibody, and is attested in many experi- 
ments where cell  subsets were identified that secreted very high 
levels of one lymphokine without detectable or with only traces 
of the other lymphokine. IFN-'y and IL-5 were measured by two- 
site sandwich ELISAs (24, 25).  Results are expressed in picomolar 
equivalents, by comparison with recombinant standards run for each 
assay. Ib2 was recombinant human protein from Hoffmann-La 
Roche  (Basel,  Switzerland),  Ib4 was mouse recombinant puri- 
fied  from  a  baculovirus  expression  system  (C.  Watson;  NIH, 
Bethesda, Maryland), Ib5 was mouse recombinant from DNAX 
(Palo  Alto,  CA),  mouse recombinant IFN-3~ was from Amgen 
(Thousand Oaks,  CA). 
Results 
The  Large  Amounts  of 11,4  Secreted  by lISA l~ CD4+8 - 
Thymocytes Reflect a High Producer Cell Frequency.  As thymo- 
cytes mature from the double-positive to the single-positive 
stage,  they progressively express  lower levels of HSA.  We 
used this marker to purify mature (HSA  l~ CD4 +  8- thymo- 
cytes, and compared their ability to secrete various lymphokines 
with that of peripheral inguinal and axillary CD4 + lymph 
node ceils upon stimulation by plate-bound anti-TCR-o~/~ 
antibodies. As previously shown (9), peripheral CD4 + calls 
produce a pattern of lymphokines that is radically different 
from that of their presumptive immediate precursor, HSA  l~ 
(mature) CD4+8 -  thymocytes (Fig. 1). LN CD4 + cells pro- 
duce mainly Ib2 and only traces of other lymphokines, such 
as II.-4 or IFN-% whereas mature CD4+8 -  thymocytes pro- 
duce low levels of IL-2, and high levels of IL-4 and 3,-IFN-y 
(370- and 60-fold more than LN cells, respectively). To de- 
lOO  L 
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I/3 
I000 
1/9604 
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2000  10  30 
1/18 
lymph node  thymus 
CD4  +  HSAIO CD4+8  - 
bulk 
stimulation 
IL-2 (pM)  345  77 
-pIFN (pM)  42  2560 
IL-4 (pM)  5  1841 
Figure 1.  Frequencies of II,2 and IL-4 producers in mature (HSA  ]~ 
CD4+8 -  thymocytes  and  peripheral  CD4 +  lymphocytes.  (O)  IL-4 
producers; (@) 11:2 producers. The 95% confidence  limits of the frequen- 
des measured were: LN I1:2, 1/2-1/4; 11:4, 1/5,930-I/14,056;  thymus 
I1:2, 1/14-1/22;  I1:4, 1/26-1/41.  For comparison, the table shows the 
amounts of lymphokines obtained in bulk stimulation of the same purified 
populations. 
termine whether the large production of Ib4 was related to 
a high frequency of producers or to a rare ceU type capable 
of secreting large amounts of this lymphokine, we measured 
the frequencies of cells secreting IL-2 or II~4 in limiting dilu- 
tion assays. We found that the differences in bulk stimula- 
tion corresponded to differences in producer frequendes. Thus, 
in the experiment shown in Fig.  1,  1/3 of LN CD4 + cells 
produced  IL-2 vs.  1/18  of mature  CD4+8 -  thymocytes. 
Conversely, 1/34 of thymic CD4 +  8- calls produced II.-4 vs. 
only 1/9,600 of LN CD4 + cells (Fig.  1). Results from sev- 
eral experiments performed in C57BL/6 or BALB/c mice are 
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,req  ~  o  i 
10-3 ~ 
I ......................  I 
IL4/IL2  i  .........................  i 
mean freq ratio  i  1/4  i 
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CD4  + 
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t .....................  1 
11_2  IL4 
1/310 
-! 
CD4  + 
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Ib 11+ 
o 
o  1/5308 
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Figure 2.  Frequencies of Ib2 
and  1I,-4 producers in  mature 
CD4 + cell popuhtions.  (O) I1:4 
producers; (e) rb2 producers.  Ex- 
periments  in which the frequency 
of I1:4 producers and that of II.,2 
producers  were  simultaneously 
measured  are  displayed in  the 
figure. The geometric mean of the 
frequendes is written on the right 
of each group of symbols. The 
geometric means of the individual 
I1:4/I1:2 frequency ratios are dis- 
played inside boxed areas at the 
bottom. 
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CD4 +8-  thymocyte able to secrete  I1-4 for four that can 
produce I1-2, whereas the proportions in spleen and lymph 
nodes have dropped to 1 for 300 and 1 for 800, respectively. 
It is not yet clear whether I1-4-producing cells are distinct 
from or included in the I1-2-producing cell population. We 
will refer however to the ratio of I1.4/I1.2 frequencies in this 
paper,  because  it provides a way to normalize the levels of 
mature,  lymphokine-seereting cells  in  CD4 +  populations 
obtained from different in vivo and in vitro systems. 
CD4+ o  ~  Thymocytes with the Capacity to Secrete IL,4 and 
IFN-"/ Are Exported to the Spleens of Adult Mice.  Two pos- 
sible general explanations could be proposed for the differ- 
ence between the frequency of I1-4 producers in the thymus 
and in the peripheral lymphoid organs. The first is that I1-4 
producers are not exported out of the thymus, and therefore 
represent either resident cells, ceils on their way to die, or 
even ceUs leaving the CD4 + pool for the CD4-8-  compart- 
ment (26-29). The second is that I1-4 producers are exported 
but they may have special circulation properties that exclude 
them from the spleen and the peripheral lymphoid organs, 
or have a very short lifespan, or perhaps convert to I1-2-only 
producers soon after reaching peripheral lymphoid organs. 
To discriminate between these alternatives,  we analyzed the 
pattern of lymphokines secreted by recent thymic migrants 
in the spleen.  Thymocytes were labeled  in situ by an in- 
trathymic injection of FITC, and FITC + CD4 + cells were 
recovered in the spleen by electronic cell sorting 10 h after 
the injection (Fig. 3). In three different experiments, 0.4-0.5% 
of the spleen  CD4 + cells were FITC + at that time point, 
a result close to that obtained by others (14). However, be- 
cause the proportion of thymic cells labeled by this technique 
was ~50% for all subpopulations including HSA  1~ CD4 +  8- 
cells (not shown), the actual proportion of migrants may be 
closer  to 0.8-1%.  As shown in Fig. 4, bulk stimulation of 
recent thymic migrants (FITC +) showed that they produced 
20-fold more I1-4 than FITC- cells (a mixture of nonlabeled 
migrants, activated/memory  cells and the majority ofperiph- 
lOO 
% neg.  10 - 
wells 
11.-2 
4  8 
IU.4 
cell number 
4o0  80O 
1/76 
RESIDENTS  MIGRANTS 
(FITC')  ￿9  (FITC  +)  O 
bulk 
stimulation 
IL-2 (pM)  189  462 
7-1FN (pM)  200  456 
IL-4 (pM)  22  475 
Figure 4.  Frequencies  of I1--2 and Ib4 producers among  recent thymic 
migrants in the spleen. The frequencies  of 1I_-2 and IL-4 producers was 
determined  in the purified  populations  of migrants (O) and residents (0) 
shown in Fig. 3. The 95% confidence  limits of the measured frequencies 
were: resident  Ib4 producers, 1/417-1/662; resident  Ib2 producers, 1/2-1/3; 
migrant Ib4 producers, 1/61-1/86; migrant  IL-2  producers, 1/3-1/4. For 
analysis of lymphokine  secretion in bulk. 6 x  104 cells were stimulated 
by TCR crosslinking,  as described in Materials and Methods. Results  are 
shown in the table at the bottom. 
ripheral, resting, I1.2-only-producing cells). The migrant cells 
also secreted IFN-% although not significantly more than 
the resident cell population, and their secretion of I1.2 was 
comparable with that of resident cells. In limiting dilution 
assays, the frequency of I1.2  producers was similar among 
migrants and residents but the frequency of 11.4 producers 
among migrants (1/76) far surpassed  that among the resi- 
dents (1/552).  Thus, the ratio of Ib4/Ib2 producers is "~lO- 
fold higher in migrants (1/19) than in residents (1/184). When 
a 
RESIDENTS 
o 
FITC 
MIGRANTS 
Figure  3.  Thymic  migrants in 
the spleen. Intrathymically  FITC- 
labeled migrants were identified 
within the splenic CD4 + compart- 
ment. (Middle) Logarithmic  display 
of  fluorescence intensities in  a 
CD4+-enriched population pre- 
pared from  the pooled spleens  of 15 
C57BL/6 mice. The gate includes 
the CD4 + cells that migrated  out 
of the thymus  during  the last 10 h: 
0.4% of the splenic CD4 + pool. 
This percentage  was calculated  from 
the analysis of 10  s CD4 + cells; 
only 1 of 10  s (0.001%) CD4 + cells 
from control uninjected  mice was 
found in the same gate. Resident- 
and migrant-enriched CD4 + cell 
popuhtiom  wel"e  obtained  by FAC~ 
sorting (/eft  and right, respectively). 
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cytes, however, the I1,4/Ib2 ratio in thymic migrants  was 
found to be decreased fivefold (compare with Fig. 2). This 
was due to both an increase of the Ib2 producer frequency 
(twofold) and a decrease in the I1,4 producer frequency (2.5- 
fold). Similar results were obtained in two additional experi- 
ments shown in Fig. 5 (see the minus 38-h time points). To 
follow the fate of the thymic migrants over time, mice were 
intrathymically  injected with FITC,  and then divided into 
three groups.  The first group was analyzed at  10 h.  Mice 
from the other two groups were thymectomized at 48 h, and 
one group was analyzed after 3 d, and the other after 6 d. 
Fig. 5 shows the evolution of the frequencies of II.-4 and I1,2 
producers and their ratio in both the migrants and the con- 
trol residents.  The frequency of II-2 producers was similar 
in both populations and did not change significantly. In con- 
trast,  a major reduction was observed over time in the fre- 
quency of I1-4 producers among the thymic migrants.  The 
frequency had already decreased an order of magnitude by 
3 d, down to  1:1,745,  threefold lower than  that of the pe- 
ripheral  residents  assayed  at  the same time.  After an addi- 
tional 3 d, the frequency was almost undetectable at 1:15,612, 
30-fold lower than the resident cells. Similar conclusions were 
obtained from bulk stimulation cultures (not shown). These 
kinetic studies establish that phenotypically activated thymic 
migrants are exported to the spleen, and they show that the 
frequency of the activated phenotype drops by 100-fold within 
a period of 6 d.  From calculations based on the measured 
rate of export, the frequency of I1,4 producers in the spleen 
and in the migrant cell population, and their functional half- 
life, we estimate that '~10% of the cells able to produce I1-4 
Table  1.  Frequencies  of IL-2 and IL-4 Producers in Newborn 
CIM *8-  Thyraocytes and CIM + Splenocytes 
Exp.  1  Exp.  2 
Newborn HSA  ]~  Newborn HSA  ]~  Newborn 
CD4 +8-  CD4 +8-  CD4* 
thymocytes  thymocytes  splenocytes 
IL-2  1/12  1/6  1/3 
IL-4  1/183  1/95  1/358 
IL-4/IL-2  1/15  1/16  1/119 
Exp. 1, 1-d-old  C57BL/6 newborns; Exp. 2, 3-d-old C57BL/6 newborns. 
in the spleen of unimmunized,  specific pathogen-free mice 
are in fact recent  thymic migrants. 
CIM § 8-  Thyraocytes Capable of Secreting II,4 Are Exported 
to the Spleen of Newborn Mice.  We have previously shown, 
using neonatal mice and fetal thymic organ culture,  that  a 
significant proportion of Ib4 producer cells in the thymus 
are not likely to be recirculating cells (9). We now asked the 
same question of the migrants.  At  1 d  after birth,  CD4 + 
cells are undetectable in the spleen, and, by day 3, they reach 
a level of only 1% of the total splenic population. We there- 
fore purified HSA  l~ CD4+8 -  calls from C57BL/6 newborn 
thymuses at days 1 and 3 after birth and compared them with 
CD4 + spleen cells  sorted at day 3. Table 1 shows that the 
ratio of IL-4 to Ib2 producers is the same (•1/15)  for thymo- 
cytes of both ages.  Thus,  at a time when the periphery is 
10-2 
10-4 
I  1 
frequency IL-2 
...........................  T ...........................  I 
frequency  IL-4 
oo 
....................................  1 ...........................  | 
-48 -38  0  72  144 
1"  1" 
FITC  TX 
8 
0 
i  .......... 
ratio IL-4/IL-2 
..........................  I ...........................  1 
Figure 5.  The fate of thymic migrants. Pools of C57BL/6 mice were injected intrathymicaUy with a solution of FITC and the frequencies of lym- 
pbokine producers among thymic migrants (O) and residents (O) in the spleen were measured 10 h later in three experiments. In one of these experi- 
ments, mice from the same pool assayed  at 10 h were thymectomized at 48 h. 3 or 6 d later, FITC  + CD4 § cells in the spleens (respectively, 2.2 and 
1.8% of the CD4 + cells, over backgrounds of 0.004 and 0.001% measured on 10  s cells) were FACS  ~ sorted and analyzed. The 95% confidence  in- 
tervals of the measured  f'requendes  of  11,4 producers  among migrant or resident cells  over  time in this e/qaeriment are represented  by the bars in the middle  figure. 
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Figure 6.  Kinetics of generation of CD4+8 -  cells in fetal thymic organ 
culture. Day 13 fetal thymuses were cultured as described in Materials and 
Methods. At the indicated time points, pools of five to six thymuses were 
collected and analyzed to measure the numbers of cells belonging to the 
various cell subsets. The number of double-positive thymocytes peaks at 
day 7 (not shown). 
virtually devoid of lymphocytes, a significant proportion of 
the  lymphokine-secreting cells  in  the  thymus  are  IL-4 
producers,  reenforcing our  previous conclusion that  I1,4 
producers are generated in the thymus. When we compared 
3-d-old splenic CD4 + cells with their thymic precursors, we 
found that the frequency of II.-4 producers had decreased four- 
fold while the frequency of II.-2 producers had increased two- 
fold, to a final ratio of 1/119,  eightfold lower than in the 
thymus. This is similar to what was observed in the adult 
thymic migration assay, where the ratio decreased fivefold, 
and supports the contention that the II,4 producer CD4 +  8- 
population generated in the thymus is exported to the spleen, 
where it soon begins to lose its capacity  to secrete I1,4. 
Kinetics of Expression of the Potential to Secrete 11..4, 11.,5, and 
IFN-'y during Fetal Thyraic Organ Culture.  In the periphery, 
the acquisition of the potential to secrete I1.-4, IL-5, and IFN-3, 
by CD4 + T  calls occurs by 2-4 d after activation (1, 3, 4, 
7, 8). We used fetal thymic organ cultures to study the timing 
of appearance of IL-4 producers, their rate of accumulation, 
and their ultimate fate as compared with Ib2 producers. Fig. 
6 shows the kinetics of the generative phase in fetal thymic 
organ culture. The number of double-positive cells peaks at 
7 d in culture (day 20 of fetal life) and CD4 +  8- reach their 
maximum number 2 d later. This sequence is similar to that 
found in fetal and newborn thymuses followed in vivo (30). 
Although HSA  l~ CD4 +  8- cells were first detected at day 7, 
neither day 7 nor day 8 HSAl~  CD4 +  8- cells pro- 
duced detectable lymphokines (including Ib2) when stimu- 
lated through the TCR (data not shown). This is presum- 
ably because these very minor subpopulations identified as 
HSA  l~ in fact bdong to the overlapping HSA  hi major popu- 
lation at these time points. Day 9 marked the appearance of 
the earliest functionally mature HSA  1~ CD4 +  8-  cells and, 
in two separate experiments, the ratio of Ib4/Ib2 frequen- 
cies at this time was 1/11 and 1/20 (Fig. 7), a result in the 
same range as that measured in newborn thymus, and 2.5-5- 
fold lower than the ratios observed in adult thymuses. With 
time, the ID4/I1,2 ratio decreased (Fig.  7, right).  Thus, it 
appears that the development and fate of I1.-4 producers in 
the organ culture system in vitro is the same as in vivo. The 
mature CD4 +  8-  population first emerges enriched in IL-4 
producers and then reverts to a mainly I1.-2 producer popula- 
tion. This is similar to what was observed a few days after 
migration of thymocytes to the spleen, and suggests that the 
disappearance  of I1,4 producers in the spleen is not simply 
frequency IL-2 
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Figure 7.  Frequencies of lymphokine producers among HSA  1~ CD4 +  8-  cells during fetal thymic organ culture.  The frequencies of lymphokine 
producers among purified HSA  1~ CD4+8 -  cells  in fetal thymic organ culture were measured at days 9, 12, and 16, and compared with those of adult 
HSA  Io CD4+8 -  thymocytes and CD4 + LN cells. In one experiment (circles), HSA  lo CD4+8 -  cells were purified at day 9 (open circles) and day 12 
(closed circles) of the same fetal thymic organ culture,  and compared each time to their homologue from fresh adult thymuses, represented in open 
and dosed circles, respectively, at the left part of each graph.  In another experiment (triangles),  HSA  l~ CD4+8 -  thymocytes were purified the same 
day from two distinct fetal thymic organ cultures set up I wk apart (days 9 and 16), and they were compared with fresh adult CD4 § LN cells (presented 
on the right part of each graph). Results are expressed as frequency values for I1:2 and II:4 producers (left and middle, respectively), or as the II.-4/I1:2 
frequency ratios (right).  The 95% confidence intervals are shown for the I1:4 producer frequencies (middle). 
736  Activation Events during Thymic Selection the result of migration to other organs but a change of state 
of the migrant cells. Table 2 shows that in addition to II.,4, 
other lymphokines characteristic of the activated stage, such 
as I1:5 and IFN-3', are also produced at day 9 by CD4 +  8- 
fetal thymocytes, and the production of II.-5 decreases with 
time, similar to I1:4.  Thus, by analogy with the sequence 
of events reported during the activation of peripheral  CD4 + 
lymphocytes (1, 3, 7, 8), the transient acquisition by HSA  1~ 
CD4 +  8- thymocytes of the potential to secrete Ib4 and II:5 
suggests that activation events have occurred 2-4 d earlier, 
between days 5 and 7 of fetal organ culture, at the double- 
positive or early immature (HSA  hi) CD4+8 -  stage. 
Sequential Expression of CD69 and CD44 during the Dif 
ferentiation of CD4 +  8-  ThymocFes.  The activation/memory 
marker CD44 is present on most peripheral CD4 + T  cells 
capable of secreting I1:4,  Ib5, and IFN-~/(4, 9, 31). CD44 
is a late activation marker that is maximally expressed within 
2-3 d after activation (32).  It is also expressed on a variable 
proportion of the CD4 +  8-  thymic subset in low expressor 
strains such as C57BL/6 and AKR (33).  Fig. 8 shows that 
it is  selectively  expressed  on the HSA  l~ cells in C57BL/6 
mice.  This  was  also  observed  in  AKK  and  BALB/c  x 
C57BL/6 mice (not shown). To test whether CD44 expres- 
sion would overlap  with the  potential to  secrete  II.-4 by 
HSA  I~ CD4 +  8-  thymocytes, we sorted CD4 +  8-  thymo- 
cytes from C57BL/6 mice into HSA  1~ CD44  hi and HSA  1~ 
CD44 l~ cells. The table at the bottom of Fig.  8 shows that 
the CD44  hi population indeed contains threefold more Ib4 
producers and fivefold fewer I1:2 producers than the CD441~ 
population. Thus, the ratio of Ib4 to Ib2 producers in the 
CD44 hi subpopulations (1/3)  is much higher than that in 
the CD44  l~ subpopulation (1/50).  In this and another ex- 
periment, analysis of the lymphokines secreted after bulk stim- 
ulation showed that IFN-3' production was exclusively found 
in the CD44  hi population (not shown). 
The chronology of events leading to the activated func- 
tional phenotype of the HSA  1~ CD4+8 -  thymocytes was 
further investigated,  using four-color cytofluorometry to 
Table  2.  Lymphokines Produced by HSA I~ CD4+8 -  Thymocytes 
from Fetal Thymic Organ Culture 
day 9  day 12 
pmol 
IL-2  133  199 
IFN-~  233  193 
IL-4  247  88 
IL-5  390  53 
After 9 or 12 d in organ culture, cells  were purified  out of the same pool 
of 200 thymuses from day 13 fetuses as used in Fig. 7 (experiment 
represented by circles) to measure IL-4 and IL-2 producer frequencies. 
3 x  104 (day  9) or 5 x  104 (day 12) CD4 + cells were stimulated  with 
plate-bound anti-TCR-cffB  mAb as described  in Materials and Methods. 
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Figure 8.  CD44 + CD4 § 8-  thymocytes  are HSA  1~  and are enriched  in 
IL-4 producers. CD4 +  8--enriched thymocytes  from 6-wk-old C57BL/6 
mice were stained  with CD4-APC, HSA-biotin  revealed  by streptavidin- 
PE, and CD44-FITC (a), before  sorting into HSA  lo CD4 + cells negative 
(b) or positive (c) for CD44. The frequency  of IL-2 and II..4 producers 
(and its 95% confidence  limits) was then measured in each population 
(table). 
follow the levels of expression  of CD69, an early activation 
marker that is induced within a few hours after activation 
(12, 34, 35).  For each thymic subset, we compared CD69 
expression with thymocyte  maturation markers such as mem- 
brane levels of TCR and HSA (Fig. 9). High levels of TCR 
were defined by reference  to the CD4+8 -  subset (f),  ab- 
sence of detectable TCR by reference to double-negative cells 
(c), and low/medium levels are in between. Low vs. high levels 
of HSA were defined by reference to splenic CD4 + cells (h). 
Fig. 9 shows that CD69 expression is directly correlated to 
TCK levels among double-positive cells. CD69 is first ex- 
pressed  on  a  minor  subset  (3%)  of  TCR  I~  double- 
positive cells  and is  then present  on  50%  of the  TCR  hi 
double-positive population (d). The majority of a presump- 
tive transitional (36) TCR  m~d CD4 +  8  I~ subset is CD69 posi- 
tive (e), as is the immature HSA  hi CD4+8 -  population (g). 
CD69  expression  drops  at  the HSA  1~ CD4+8 -  stage (g), 
thus showing a reciprocal distribution with CD44 (compare 
with Fig. 8),  and remains low on the vast majority of pe- 
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Figure 9.  CD69 e~ession during 
thymocyte development. Four-color 
analysis of tbymocytes and spleno- 
cytes from a 6-wk-old AKR mouse. 
a (thymus) and b (spleen) show the 
gates  used  for  analysis  of  the 
different subpopulations. The gate 
defining CD69-positive vs. negative 
cells is set by reference to the back- 
ground staining in the presence of 
a 100-fold  ear.ess of unlabeled CD69 
antibody. This gate does not apply 
for the TCR- CD4-8-  cells (c), 
which have a higher level of auto- 
fluorescence than  the  other  sub- 
populations, and are all CD69 nega- 
tive (not shown). 
ripheral CD4 + lymphocytes (h). The faint apparent labeling 
of TCR-  double-negative thymocytes (c) is  in  fact non- 
specific, due to a higher level of autofluorescence of this popu- 
lation, because it is not modified by a 100-fold excess of un- 
conjugated anti-CD69 antibody (not shown). Double-negative 
thymocytes expressing intermediate levels of TCR were con- 
sistently found to contain 60-70% CD69 + cells (c). Similar 
results  were found in  all  strains  tested,  including AKR, 
C57BL/6, BALB/c, and BALB/c x  C57BL/6. In particular, 
the highest  proportions  of CD69 +  cells  (50-90%)  were 
always found among "transitional" TCR  m~d CD4 +  8  l~ cells, 
HSA  hi TCR  ~a double-positive cells and HSA  hs CD4 +  8- cells. 
Because the CD69 antigen is expressed within a few hours 
after stimulation of peripheral cells (12, 34, 35), these results 
suggest  that  the  thymic  activation  events  occur  at  the 
TCR  l~  double-positive stage. 
Discussion 
The experiments described in this paper were initiated to 
explore the intrathymic pathway leading to the generation 
of IL-4 producer CD4+8 -  thymocytes, in terms of rates of 
production and export, and to understand the origin of this 
unexpected  phenotype.  By  most  criteria  examined,  this 
pathway appears  to identify the normal process of thymic 
selection and export to the periphery of CD4 + T lympho- 
cytes. The Ib4 producer stage of the HSA  l~ CD4 § 8- popu- 
lation correlates with the expression of the CD44 late activa- 
tion  marker,  and  follows a  stage where HSA  hi CD4+8 - 
thymocytes transiently express  the early activation marker 
CD69 and are IL-2-only producers. By the time when HSA  l~ 
CD4+8-  thymocytes get exported to the periphery, they 
progressively revert to the resting phenotype (CD44  l~  Ib 
2-only-producer) observed for  the  majority of peripheral 
CD4 §  T  cells.  These sequential events are reminiscent of 
changes observed in peripheral CD4 + T  cells after activa- 
tion and suggest the hypothesis that thymocyte selection is 
also an activation process. 
We found that the frequency of cells able to secrete II:4 
is extraordinarily high among mature CD4 +  8- thymocytes. 
On average, one IL-4 producer was found for every four Ib2 
producers. Such a high proportion of I1.,4 producers has no 
known equivalent in lymphoid organs: the bulk production 
as well as the frequency of mature CD4 + cells capable of 
secreting Ib4 in the thymus is 30-800-fold above that found 
in  other lymphoid compartments in  the body,  including 
spleen, peripheral and mesenteric lymph nodes, blood and 
thoracic duct (9), and also peri-thymic lymph nodes (our un- 
published observations),  or Peyer's patches (2). 
We next showed that these CD4 § 8-  thymocytes are ex- 
ported to the periphery: first by labeling the thymocytes in 
vivo with FITC and collecting the recent thymic migrants 
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CD4 + cells present in the spleens  of unmanipulated, 3-d- 
old newborns, that is, 2-3 d after the first mature CD4+8 - 
thymocytes become detectable in the thymus. Ib4 producer 
cells were present in both types of migrating population in 
great excess over what would be expected from a population 
of normal virgin, resting peripheral cells. In both cases, how- 
ever, it was found that the frequency of recently migrated 
cells with this phenotype was lower than in the thymus. Soon 
after export to the spleen, the ratio of IL-4/IL-2 frequencies 
had decreased "~5 fold. 3 d after export, the frequency of II:4 
producers had dropped by another ,vl0-fold in adult thymec- 
tomized mice, and it dropped 10-fold further after an addi- 
tional 3 d so as to leave a prototypical resting, naive periph- 
eral population such as the one described, for example, in 
human cord blood (5, 6) (where the immune system is ma- 
ture at 14-15 wk of gestation and the exported T  cells are 
secluded from environmental antigens). The possibility that 
the II~4-secreting cells had in fact left the spleen for another 
compartment during the time of the study was argued against 
by the thymic organ culture experiments. In these experi- 
ments, a decrease in the frequency of IL-4 producers was also 
observed with time, while the frequency of II.-2 producers 
remained stable.  These results suggest that the drop in the 
frequency of II.-4 producers is related to their conversion to 
the resting, IL-2-only secretor phenotype, although the formal 
possibility remains that the IL-4 producers generated in the 
thymus constitute a short-lived, separate lineage. 
To verify that the thymic steady-state levels of IL-4 producers 
reflect a high production rate rather than a slow export rate, 
we followed the early generation of these cells in the se- 
questered environment provided by the in vitro fetal thymic 
organ culture system. We found that the frequency of IL-4 
producers peaked as soon as mature cells were generated, both 
in absolute and in relative (compared with the I1:2 frequency) 
numbers, by day 9 in culture. The peak ratios were as high 
as one II.-4 producer for 10-20 IL-2 producers, similar to the 
ratios measured in vivo in day 1 and day 3 newborns. Al- 
together, these results suggest that the thymus generates and 
exports  a  significant  proportion  of II~4  producer  CD4 + 
cells. 
What mechanism generates these 1I.-4 producer CD4 +  8- 
thymoeytes? In the periphery, the functional property to se- 
crete IL-4 upon stimulation is tightly correlated to activa- 
tion markers such as a low cell density (2) and the surface 
expression of activation/memory markers, in particular of 
CD44 (4, 9).  We found that CD44 h~ CD4 § 8-  thymocytes 
are indeed enriched in IL-4 producers (II,4/IL-2 producer ratio 
of 1/3)  as compared with their CD44 l~ counterpart (ratio 
of 1/50). In addition, the forward scatter index and the den- 
sity of HSA  1~ CD4+8 -  thymocytes are those of activated 
rather than resting cells (data not shown). Thus, by these 
criteria, IL-4 producer CD4 +  8- thymocytes appear to be in 
an activated state. 
What could be the origins of these activated cells in the 
mature  thymic CD4+8 -  compartment?  Aside  from  the 
thymic selection process itself, which may account for all 
the activation observed, two other potential sources of acti- 
vated cells could contribute to some extent to the population 
described in this paper: mature peripheral cells recirculating 
back to the thymus (37-44),  which may mainly consist of 
activated cells (42), and early cells that have been immunized 
in the medulla before leaving to reach peripheral organs (45, 
46, and Guerder, S., and P. Matzinger, manuscript submitted 
for publication). Because both these cell populations would 
only exist in adult thymuses but not in newborn thymuses 
or in fetal thymic organ culture, they could only account for 
the  threefold difference in  the relative frequency of II.-4 
producers at the fetal/newborn and the adult stages. An al- 
ternative possibility to explain the threefold difference is that 
the stem cells and/or the thymic microenvironment in the 
newborn are different from the adult, as has been suggested 
by many reports (30,  47-51). 
Mature CD4 +  8- thymocytes have a rather long period of 
residency in the medulla, between 1 and 2 wk (52).  Since 
it takes only 2-4 d to prime a resting cell to become an Ib4 
producer (1, 3, 7), thymocyte activation could in theory occur 
at various times, from the TCP~  med double-positive stage to 
the  HSA  l~ CD4+8 -  stage  itself.  To  identify the  precise 
timing of the activation event in the thymus, we first per- 
formed kinetic studies of the activation-related changes. In 
both fetal thymic organ culture and in newborn mice, the 
potential to secrete Ib4,  IL-5, and IFN-3~ was present and 
at peak levels as soon as mature HSA  1~ cells were detectable. 
Thus,  this property is already maximal at the early HSA  1~ 
stage. In addition, because the CD69 early activation marker 
first appears  on a minor subset  of the TCR  l~  double- 
positive thymic population, at the stage when the selection 
process is expected to operate (36, 53), and is expressed on 
50-90%  of the cells at the presumptive "transitional" HSA  hi 
TCK  hi double-positive and HSA  hi TCR  m~d CD4 +  8 l~ stages 
as well as on a majority of the HSA  h~ CD4+8 -  cells,  the 
simplest hypothesis is that the bulk of the activation was im- 
parted by the thymic selection process itself. 
The extent to which the CD4+8 -  thymic population ap- 
pears activated is different, depending on the markers studied: 
up to 70-90%  express CD69 at the HSA  hi stage,  whereas 
3%  have  the  functional capacity  to  produce  IL-4 at  the 
HSA  1~ stage.  Even after correction for possible suboptimal 
in vitro stimulation conditions for lymphokine production, 
for example, by considering the IL-4/IL-2 ratio rather than 
the absolute frequency measured for the Ib4 producers, there 
would be at most 25% of the HSA  l~ CD4+8 -  thymocytes 
that are IL-4 producers. CD44 expression is observed on 2-10% 
of the CD4 +  8- thymocytes (and on an approximately three- 
fold larger fraction of the mature HSA  1~ CD4 +  8-  popula- 
tion) depending on age and on the mouse strain (32, 33, and 
data not shown), and CD44 hi cells are enriched (although 
only threefold by comparison to CD441~  in Ib4 producers. 
If every cell being selected goes through the same pheno- 
typic sequence, these differences in expression could reflect 
different periods  of retention  for each of the phenotypic 
markers of activation.  Alternatively, the CD44  hi IL-4 pro- 
ducer phenotype may result from high af~nity interactions 
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the other during the selection process. It is also possible that 
the CD44  hi subpopulation is generated by a second stimulus 
encountered late in development, e.g., self-antigens  selectively 
expressed in the medulla, but not in the cortex (54-56). In- 
terestingly,  there is an increased  frequency of TCR-V~8 + 
cells  among  those adult  HSA  1~ CD4+8 -  thymocytes that 
have an activated phenotype, as defined by levels of expres- 
sion of markers  such as Ly-6C (27),  or CD44,  3Gll,  and 
ME1:14 (Hayakawa et al., manuscript submitted for publica- 
tion),  and it has been proposed that these cells may belong 
to an intrathymic pathway leading to the generation of ma- 
ture,  TCR-od~  double-negative thymocytes, possibly as a 
way to impart tolerance (27, Hayakawa, K., B. T. Lin, and 
R. R. Hardy, manuscript  submitted for publication).  This 
raises  the question of whether  all  I1:4 producer CD4+8 - 
thymocytes are destined to end up in this pathway. We think 
that  their high rate of production and export, even in the 
newborn period, weeks before a significant increase in V~8 + 
cells, is detected (27, Hayakawa et al., manuacript submitted 
for publication), argues against this hypothesis. CD441~ I1:4 
producers are likely to be the cells exported to the periphery, 
based on their lymphokine secretion potential  which is similar 
to that of thymic migrants (compare Figs. 4 and 8), and the 
report that thymic migrants are mainly CD44  l~ (57).  Future 
experiments  are needed to clarify the relationship  between 
CD44  hi and  CD441~ I1:4 producers  and  to determine  the 
origin, rate of generation,  and the fate of the VB8 pathway 
of CD4 § 8-  thymocyte differentiation. 
At  present,  the  signals  transduced  by the TCR during 
thymic selection are unknown, as are their consequences. It 
is also unclear which one of several potential receptors, aside 
from the TCR/CD3 complex, including CD28, Thy-1, or 
CD2, will transduce the first activating signals. We have found 
that the TCR seems deficient in its ability to transduce signals 
leading to lymphokine secretion (9) or even lymphokine re- 
sponsiveness (our unpublished observations) until the HSA  1~ 
CD4 + 8-  stage,  although other biochemical responses, such 
as calcium fluxes, can be elicited to some extent (58). Thus, 
although  a full activation leading to lymphokine secretion 
and expansion probably does not occur, several well-defined 
activation markers can be identified as a result of the selec- 
tion process, such as the expression of the surface activation 
antigen  CD69  (previously  reported  on  human  TCK  hi 
thymocytes [34]), of CD44,  and of the potential to secrete 
the lymphokines  II:4,  I1:5,  I1:10,  and IFN-3'. 
In conclusion,  the sequence and the extent of induction 
of several activation markers during thymic ontogeny sug- 
gest that thymic selection is not simply a rescue from pro- 
grammed cell death, but involves an activation process that 
can be followed by a series of markers,  and that is still evi- 
dent  after export  to the periphery. 
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